✦ LIBER ✦

The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB

✍ Scribed by Hamid Khaloozadeh; Pedram Yazdanbakhsh; Fatemeh Homaei-shandiz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of reduced dose intensity in

✍ Michelle Shayne; Jeffrey Crawford; David C. Dale; Eva Culakova; Gary H. Lyman; f 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 295 KB

Very low-dose adjuvant chemotherapy in s

✍ R. Jakesz; H. Samonigg; M. Gnant; E. Kubista; P. Steindorfer; H. Hausmaninger; P 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Dose variation and regimen modification

✍ Sung-Hsin Kuo; Huang-Chun Lien; San-Lin You; Yen-Shen Lu; Ching-Hung Lin; T.-Zui 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Are Dose-Dense and Triplet Chemotherapy

✍ Moylan, E. J.; Connell, L. C.; O'Reilly, S. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 59 KB

The incidence of symptomatic thromboembo

✍ Luke Nolan; Angela Darby; Katia Boleti; Peter Simmonds 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 149 KB

P103 Toxicity and tolerability of the an

✍ A. Jagiello-Gruszfeld; A. Lowczak; J. Zbrzezniak-Smilgiewicz; S. Szablowska-Siwi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB